Indomethacin in the management of rheumatoid and osteoarthritic diseases
Soler-Bechara, J.
Boletin de la Asociacion Medica de Puerto Rico 60(6): 275-278
1968
ISSN/ISBN: 0004-4849 PMID: 5249666 Document Number: 701166
Document emailed within 1 workday
Related Documents
Sturrock, R.; Isaacs, A.; Hart, F.D. 1975: Feprazone compared with indomethacin in the management of rheumatoid arthritis Practitioner 215(1285): 94-97Torgyán, S.; Wagner, L.; Neumann, T.; Pakuts, B.; Csányi, M. 1979: A comparative study with indomethacin and combined indomethacin sodium-salicylate in rheumatoid arthritis International Journal of Clinical Pharmacology and Biopharmacy 17(11): 439-441
Ghosh, P.; Ingman, A.M.; Taylor, T.K. 1975: Variations in collagen, non-collagenous proteins, and hexosamine in menisci derived from osteoarthritic and rheumatoid arthritic knee joints Journal of Rheumatology 2(1): 100-107
Burton, W.D.; Hazleman, B.L. 1983: Fenbufen and indomethacin: a comparative study in rheumatoid arthritis Clinical Therapeutics 5(3): 260-267
Domljan, Z.; Durrigl, T. 1983: Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis European Journal of Rheumatology and Inflammation 6(3): 291-296
Desai, M.M.; Shetty, R.N. 1977: Double-blind crossover comparison of naproxen and indomethacin in rheumatoid arthritis Journal of the Association of Physicians of India 25(10): 703-707
Shichikawa, K.; Aritomi, H.; Ogawa, N. 1982: A double-blind multi-center clinical trial of benoxaprofen against indomethacin in rheumatoid arthritis Ryumachi 22(1): 88-102
Bröll, H. 1981: Long-term, double-blind, between patients comparison of indoprofen and indomethacin in rheumatoid arthritis European Journal of Rheumatology and Inflammation 4(1): 126-134
Miehle, W.; Rehs, E.L.; Zollner, E. 1981: Local rheumatoid therapy. Indomethacin level in the synovia and serum after application of Amuno ointment Fortschritte der Medizin 99(44): 1830-1833
Caldwell, J.R.; Germain, B.F.; Lourie, S.H.; McLaughlin, G.E.; Poiley, J.E.; Vreede, P.D.; Wilson, C.H. 1988: Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study Journal of Rheumatology 15(10): 1476-1479
Das Gupta, A.Bijoy.; Hossain, A.K.M.Mosharrof.; Islam, M.Hilalul.; Dey, S.Ranjan.; Khan, A.Latif. 2009: Role of omega-3 fatty acid supplementation with indomethacin in suppression of disease activity in rheumatoid arthritis Bangladesh Medical Research Council Bulletin 35(2): 63-68
Adebajo, A.O.; Cawston, T.E.; Hazleman, B.L. 1994: Rheumatoid factors in association with rheumatoid arthritis and infectious diseases in West Africans Journal of Rheumatology 21(5): 968-969
Varese, L.A.; Antoniola, P. 1970: On the use of indomethacin in the treatment of renal diseases in childhood Minerva Pediatrica 22(28): 1440-1443
De Marzi, S.; Morini, V. 1972: Use of meglumine indomethacin in the treatment of pain due to neoplastic diseases La Clinica Terapeutica 62(2): 175-180
Nagy, L.; Mózsik, G.; Feledi, E.; Ruzsa, C.; Vezekényi, Z.; Jávor, T. 1984: Gastric microbleeding measurements during one day treatment with indomethacin and indomethacin plus sodium salicylate (1 : 10) in patients Acta Physiologica Hungarica 64(3-4): 373-377
Iversen, O.; Fowles, M.; Vlieg, M.; Smidt, N.; Wigley, R. 1981: Sustained release indomethacin: a double blind comparison with indomethacin suppositories New Zealand Medical Journal 93(682): 261-262
Szigeti, L.; Bolgár, J. 1981: Effectiveness of indomethacin in the management of childhood and juvenile primary dysmenorrhea Orvosi Hetilap 122(30): 1871
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Vaishnava, H.; Dasgupta, M.K.; Sachar, M.S. 1971: Treatment of articular and non-articular (rheumatic diseases by indomethacin suppositories) Journal of the Association of Physicians of India 19(2): 157-165
Azuma, T. 1988: Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 4) Rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 883-887